Literature DB >> 17810417

The Mechanism of Cysteine and Glutathione Protection Against Alloxan Diabetes.

A Lazarow, J W Patterson, S Levey.   

Abstract

Entities:  

Keywords:  CYSTINE AND CYSTEINE; DIABETES/alloxan; GLUTATHIONE/therapy

Mesh:

Substances:

Year:  1948        PMID: 17810417     DOI: 10.1126/science.108.2803.308

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

1.  The glutathione content of blood and tissues following alloxan and dehydroascorbic acid injections.

Authors:  S K BHATTACHARYA; J S ROBSON; C P STEWART
Journal:  Biochem J       Date:  1956-01       Impact factor: 3.857

2.  [Prevention of diabetogenic effect of alloxan by preceding administration of glucose].

Authors:  H MASKE; H WOLFF; B STAMPFL
Journal:  Klin Wochenschr       Date:  1953-01-15

3.  Studies on alloxan diabetes. I. Increase of susceptibility caused by acetoacetate.

Authors:  M C NATH; J S GADGIL; V G HATWALNE
Journal:  Biochem J       Date:  1953-02       Impact factor: 3.857

4.  Diabetes and Gout.

Authors: 
Journal:  Br Med J       Date:  1949-09-24

5.  [The protective effect of cysteine in dithizone diabetes].

Authors:  F BAUMGARTEN; H WOLFF; H MASKE; B STAMPFL
Journal:  Klin Wochenschr       Date:  1952-01-15

Review 6.  Alloxan: history and mechanism of action.

Authors:  S Lenzen; U Panten
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

Review 7.  The mechanisms of alloxan- and streptozotocin-induced diabetes.

Authors:  S Lenzen
Journal:  Diabetologia       Date:  2007-12-18       Impact factor: 10.122

8.  Ameliorative effect of Cephalandra indica homeopathic preparation in STZ induced diabetic nephropathy rats.

Authors:  Lalit Kishore; Randhir Singh
Journal:  J Ayurveda Integr Med       Date:  2018-11-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.